Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

INDGN IB​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings
Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

INDGN IB​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

Indegene Limited(INDGN IB)

$613.65-3.400.55%(Market Closed · 09:59:02 UTC · (15 min delay))
ProfileEntity StructureFinancialsChartingEmployees

Overview

ProfileEntity Structure

Financials & Metrics

FinancialsChartingEmployees

Indegene Limited(INDGN IB)

$613.65-3.400.55%(Market Closed · 09:59:02 UTC · (15 min delay))
ProfileEntity StructureFinancialsChartingEmployees

Overview

ProfileEntity Structure

Financials & Metrics

FinancialsChartingEmployees
Ask AI
Ask AI

Indegene Limited — Company Profile

Operating globally with a strong presence in India, Indegene Limited functions as a specialized commercialization partner for the life sciences industry. It provides comprehensive support to biopharmaceutical, emerging biotech, and medical device companies, assisting them from product development and market access to maximizing their impact throughout the product lifecycle. The company's service offerings include enterprise commercial, medical, and clinical solutions, coupled with omnichannel activation strategies and proprietary NEXT technology platforms. Indegene was established in 1998 and its principal operations are based in Bengaluru, India.

Sector
Healthcare
Industry
Medical - Healthcare Information Services
Exchange
IB
CEO
Manish Gupta
Headquarters
Bengaluru, KA, IN
IPO Date
May 13, 2024
Employees
4,687
Website
www.indegene.com

Key Metrics

Price
$600.00
Market Cap
$144.57B
Revenue (TTM)
$35.10B
Net Income (TTM)
$4.01B
EPS (TTM)
16.72
P/E (TTM)
36.04
P/B (TTM)
4.61
Dividend Yield
33.39%
ROE (TTM)
12.78%
ROA (TTM)
8.68%
Operating Margin
14.03%
Beta
0.12

Dividends

Last Dividend
$2.00
Last Yield
0.33%

Summary

Operating globally with a strong presence in India, Indegene Limited functions as a specialized commercialization partner for the life sciences industry. It provides comprehensive support to biopharmaceutical, emerging biotech, and medical device companies, assisting them from product development and market access to maximizing their impact throughout the product lifecycle. The company's service offerings include enterprise commercial, medical, and clinical solutions, coupled with omnichannel activation strategies and proprietary NEXT technology platforms. Indegene was established in 1998 and its principal operations are based in Bengaluru, India.

Website
www.indegene.com
Location
Bengaluru, KA, IN
Phone91 80 4674 4567
Employees4,687
CEOManish Gupta
SectorHealthcare
IndustryMedical - Healthcare Information Services
IPO DateMay 13, 2024

Ask AI

Company overview
Business model, segments, and competition.
Peer comparison
Metrics vs closest competitors.
Guidance & outlook
Forward guidance and assumptions.
Bull vs bear case
Upside drivers and key risks.
Valuation snapshot
Multiples vs history and peers.
Competitive moat
Defensibility and market position.
Management track record
Leadership and capital allocation history.
How it makes money
A short diagram of the business model.

Key Stats

Trading

Px/Chg 1D$600.00 / +1.01%
Prev Close$582.80
% of 52Wk H99.35%
Avg Volume70.21K
Beta0.12
Mkt Cap144.57B
FD Mkt Cap147.46B

Float

Shrs Out/Float240.95M / 84.38M
Short Float0.00%
Days to Cover0.00
Stock Repurchased$0.00

Current Valuation

EV142.20B
EV/EBITDA20.91
EV/Sales4.05
P/B4.61
P/S4.12
FCF Yield4.28%
ROE12.78%
ROA8.68%
Current Ratio2.41

Dividend

Cash$2.00
Yield33.39%
Yield (TTM)33.39%

Estimates

P/E36.04
Est P/E0.00
Est EPS4.55
Est PEG0.00

Valuation

Metric5Yr AvgJun '24Jun '25Oct '26
PRICE-BASED RATIOS
Price / Earnings112.4939.46116.61181.40
Price / Sales12.565.1318.1514.41
Price / Book Value6.389.305.244.61
Price / Free Cash Flow16.6926.730.0023.35
ENTERPRISE VALUE METRICS
Enterprise Value137,490.9135,872.1134,402.9142,197.6
Enterprise Value / Sales12.405.2517.7914.17
Enterprise Value / EBITDA62.6523.3977.6486.92
Enterprise Value / EBIT77.2826.9188.19116.75

Financials

Full Financials
Millions INR5Yr CAGR (%)Mar '22Mar '23Mar '24Mar '25Mar '26
INCOME STATEMENT
Revenue20.5%16,646.123,061.025,896.028,393.035,105.0
Gross Income-26.2%16,646.123,061.025,896.028,393.04,926.0
EBITDA23.7%2,646.24,541.15,810.06,415.06,190.0
EBIT20.8%2,311.73,943.05,049.05,613.04,926.0
Net Income24.9%1,647.62,661.03,367.04,067.04,011.0
EPS (Diluted)24.6%6.8911.1214.0917.0216.62
BALANCE SHEET
Cash & ST Inv24%6,262.87,113.49,851.016,643.014,814.0
Total Assets35.9%13,534.722,038.725,456.033,259.046,203.0
Total Liabilities25.9%5,895.711,401.411,165.07,103.014,816.0
Total Shareholder Equity42.4%7,639.010,637.214,291.026,156.031,387.0
CASH FLOW
Net Operating Cash Flow22.2%2,970.41,302.25,077.04,419.06,634.0
Cap Ex15.7%-247.1-188.3-107.0-300.0-443.0
Free Cash Flow22.8%2,723.31,113.84,970.04,119.06,191.0

Enterprise Value Bridge

Millions INR26 Oct '26
Price (As of 26 Oct '26)586.60
Basic Shares240.95
Market Cap141,343.8
Diluted Shares241.34
Fully Diluted Shares Outstanding241.34
Fully Diluted Market Cap141,567.7
+Consolidated Debt1,444.0
−In-the-Money Convertible Debt—
+Capital Leases1,050.0
+Operating Leases—
−Cash & Equivalents-3,819.0
−Short-term Investments-10,995.0
+Total Preferred-
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Non-Controlling Interest-
+Pension Liabilities—
Enterprise Value138,968.8

Related companies

BrightSpring Health Services, Inc.

BTSG US

Pro Medicus Ltd./ADR

PMCUF US

Hinge Health, Inc.

HNGE US

Alibaba Health Information Technology Limited/ADR

ALBBY US

Doximity, Inc.

DOCS US

Heartflow, Inc.

HTFL US

Privia Health Group, Inc.

PRVA US

Winning Health Technology Group Co., Ltd.

300253 CS

JMDC Inc.

4483 JT

Certara, Inc.

CERT US

Pennant Group, Inc.

PNTG US

U S Physical Therapy Inc /NV

USPH US

Indegene Limited — Company Profile

Operating globally with a strong presence in India, Indegene Limited functions as a specialized commercialization partner for the life sciences industry. It provides comprehensive support to biopharmaceutical, emerging biotech, and medical device companies, assisting them from product development and market access to maximizing their impact throughout the product lifecycle. The company's service offerings include enterprise commercial, medical, and clinical solutions, coupled with omnichannel activation strategies and proprietary NEXT technology platforms. Indegene was established in 1998 and its principal operations are based in Bengaluru, India.

Sector
Healthcare
Industry
Medical - Healthcare Information Services
Exchange
IB
CEO
Manish Gupta
Headquarters
Bengaluru, KA, IN
IPO Date
May 13, 2024
Employees
4,687
Website
www.indegene.com

Key Metrics

Price
$600.00
Market Cap
$144.57B
Revenue (TTM)
$35.10B
Net Income (TTM)
$4.01B
EPS (TTM)
16.72
P/E (TTM)
36.04
P/B (TTM)
4.61
Dividend Yield
33.39%
ROE (TTM)
12.78%
ROA (TTM)
8.68%
Operating Margin
14.03%
Beta
0.12

Dividends

Last Dividend
$2.00
Last Yield
0.33%

Summary

Operating globally with a strong presence in India, Indegene Limited functions as a specialized commercialization partner for the life sciences industry. It provides comprehensive support to biopharmaceutical, emerging biotech, and medical device companies, assisting them from product development and market access to maximizing their impact throughout the product lifecycle. The company's service offerings include enterprise commercial, medical, and clinical solutions, coupled with omnichannel activation strategies and proprietary NEXT technology platforms. Indegene was established in 1998 and its principal operations are based in Bengaluru, India.

Website
www.indegene.com
Location
Bengaluru, KA, IN
Phone91 80 4674 4567
Employees4,687
CEOManish Gupta
SectorHealthcare
IndustryMedical - Healthcare Information Services
IPO DateMay 13, 2024

Ask AI

Company overview
Business model, segments, and competition.
Peer comparison
Metrics vs closest competitors.
Guidance & outlook
Forward guidance and assumptions.
Bull vs bear case
Upside drivers and key risks.
Valuation snapshot
Multiples vs history and peers.
Competitive moat
Defensibility and market position.
Management track record
Leadership and capital allocation history.
How it makes money
A short diagram of the business model.

Key Stats

Trading

Px/Chg 1D$600.00 / +1.01%
Prev Close$582.80
% of 52Wk H99.35%
Avg Volume70.21K
Beta0.12
Mkt Cap144.57B
FD Mkt Cap147.46B

Float

Shrs Out/Float240.95M / 84.38M
Short Float0.00%
Days to Cover0.00
Stock Repurchased$0.00

Current Valuation

EV142.20B
EV/EBITDA20.91
EV/Sales4.05
P/B4.61
P/S4.12
FCF Yield4.28%
ROE12.78%
ROA8.68%
Current Ratio2.41

Dividend

Cash$2.00
Yield33.39%
Yield (TTM)33.39%

Estimates

P/E36.04
Est P/E0.00
Est EPS4.55
Est PEG0.00

Valuation

Metric5Yr AvgJun '24Jun '25Oct '26
PRICE-BASED RATIOS
Price / Earnings112.4939.46116.61181.40
Price / Sales12.565.1318.1514.41
Price / Book Value6.389.305.244.61
Price / Free Cash Flow16.6926.730.0023.35
ENTERPRISE VALUE METRICS
Enterprise Value137,490.9135,872.1134,402.9142,197.6
Enterprise Value / Sales12.405.2517.7914.17
Enterprise Value / EBITDA62.6523.3977.6486.92
Enterprise Value / EBIT77.2826.9188.19116.75

Financials

Full Financials
Millions INR5Yr CAGR (%)Mar '22Mar '23Mar '24Mar '25Mar '26
INCOME STATEMENT
Revenue20.5%16,646.123,061.025,896.028,393.035,105.0
Gross Income-26.2%16,646.123,061.025,896.028,393.04,926.0
EBITDA23.7%2,646.24,541.15,810.06,415.06,190.0
EBIT20.8%2,311.73,943.05,049.05,613.04,926.0
Net Income24.9%1,647.62,661.03,367.04,067.04,011.0
EPS (Diluted)24.6%6.8911.1214.0917.0216.62
BALANCE SHEET
Cash & ST Inv24%6,262.87,113.49,851.016,643.014,814.0
Total Assets35.9%13,534.722,038.725,456.033,259.046,203.0
Total Liabilities25.9%5,895.711,401.411,165.07,103.014,816.0
Total Shareholder Equity42.4%7,639.010,637.214,291.026,156.031,387.0
CASH FLOW
Net Operating Cash Flow22.2%2,970.41,302.25,077.04,419.06,634.0
Cap Ex15.7%-247.1-188.3-107.0-300.0-443.0
Free Cash Flow22.8%2,723.31,113.84,970.04,119.06,191.0

Enterprise Value Bridge

Millions INR26 Oct '26
Price (As of 26 Oct '26)586.60
Basic Shares240.95
Market Cap141,343.8
Diluted Shares241.34
Fully Diluted Shares Outstanding241.34
Fully Diluted Market Cap141,567.7
+Consolidated Debt1,444.0
−In-the-Money Convertible Debt—
+Capital Leases1,050.0
+Operating Leases—
−Cash & Equivalents-3,819.0
−Short-term Investments-10,995.0
+Total Preferred-
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Non-Controlling Interest-
+Pension Liabilities—
Enterprise Value138,968.8

Related companies

BrightSpring Health Services, Inc.

BTSG US

Pro Medicus Ltd./ADR

PMCUF US

Hinge Health, Inc.

HNGE US

Alibaba Health Information Technology Limited/ADR

ALBBY US

Doximity, Inc.

DOCS US

Heartflow, Inc.

HTFL US

Privia Health Group, Inc.

PRVA US

Winning Health Technology Group Co., Ltd.

300253 CS

JMDC Inc.

4483 JT

Certara, Inc.

CERT US

Pennant Group, Inc.

PNTG US

U S Physical Therapy Inc /NV

USPH US